Mirae Asset Global ETFs Holdings’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$295K Buy
21,023
+218
+1% +$2.94K ﹤0.01% 2164
2025
Q4
$234K Sell
20,805
-167
-0.8% -$1.91K ﹤0.01% 2277
2025
Q3
$242K Sell
20,972
-3,574
-15% -$41.9K ﹤0.01% 2229
2025
Q2
$300K Sell
24,546
-2,409
-9% -$30.3K ﹤0.01% 2071
2025
Q1
$386K Buy
26,955
+1,121
+4% +$17.5K ﹤0.01% 2001
2024
Q4
$411K Buy
25,834
+901
+4% +$17.8K ﹤0.01% 2020
2024
Q3
$599K Buy
24,933
+2,155
+9% +$49.3K ﹤0.01% 1831
2024
Q2
$454K Buy
+22,778
New +$444K ﹤0.01% 1868

Other funds holding AVNS

Mirae Asset Global ETFs Holdings's AVNS Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Avanos Medical (AVNS) stake by 1% in Q1 2026, buying an estimated $2.94K and bringing the position to 21,023 shares worth $295K. The position accounts for ﹤0.01% of the portfolio, ranked #2164.

Mirae Asset Global ETFs Holdings first reported a position in AVNS in Q2 2024 and has held it in 8 quarters since. The position peaked at $599K in Q3 2024. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 21,023 shares of Avanos Medical worth $295K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 218 Avanos Medical shares in Q1 2026, an estimated $2.94K.
  • Avanos Medical made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2164 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Avanos Medical in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Avanos Medical position peaked at $599K in Q3 2024.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.